Many studies have demonstrated the ability of irisin to traverse the blood-brain barrier, which suggests that administration of exogenous irisin medication holds promise as a viable therapeutic approach for addressing dementia and cognitive impairment in the future. Here, FNDC5 is linked to dementia.